KBC On Other Exchanges
Symbol
Exchange
Natl India

krebs biochemicals & industr (KBC) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KREBS BIOCHEMICALS & INDUSTR (KBC)
\

Related News

No related news articles were found.

krebs biochemicals & industr (KBC) Related Businessweek News

No Related Businessweek News Found

krebs biochemicals & industr (KBC) Details

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products are used in anti-cholesterol and steroid intermediate applications. The company is also developing various products for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was founded in 1991 and is headquartered in Hyderabad, India.

Founded in 1991

krebs biochemicals & industr (KBC) Top Compensated Officers

MD & Whole Time Director
Total Annual Compensation: --
Company Secretary & Compliance Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2018.
krebs biochemicals & industr
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019

Krebs Biochemicals & Industries Limited announced earnings results for the fourth quarter ended March 31, 2019. For the fourth quarter, the company announced total revenue was INR 118.728 million compared to INR 103.598 million a year ago. Net loss was INR 52.087 million compared to INR 74.735 million a year ago. Basic loss per share was INR 3.45 compared to INR 5.99 a year ago. Diluted loss per share was INR 4.16 compared to INR 5.99 a year ago. For the full year, total revenue was INR 480.886 million compared to INR 339.852 million a year ago. Net loss was INR 200.115 million compared to INR 178.249 million a year ago. Basic loss per share was INR 12.83 compared to INR 14.01 a year ago. Diluted loss per share was INR 15.46 compared to INR 14.01 a year ago.

Pavuluri & Co. to Retire as Statutory Auditors of Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited announced that at its board meeting held on May 20, 2019, the board approved the appointment of M/s. Bhavani & Co., Chartered Accountants as Statutory Auditors of the company subject to approval by the Shareholders of the company in place of M/s. Pavuluri & Co., who retires at the upcoming annual general meeting as per the provisions of Section 139 Companies Act, 2013.

Krebs Biochemicals & Industries Limited to Report Q4, 2019 Results on May 20, 2019

Krebs Biochemicals & Industries Limited announced that they will report Q4, 2019 results on May 20, 2019

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

KBC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KBC.
View Industry Companies
 

Industry Analysis

KBC

Industry Average

Valuation KBC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KREBS BIOCHEMICALS & INDUSTR, please visit krebsbiochem.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.